KKKarolina Kubala

Karolina Kubala

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Karolina Kubala has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Exercise Volume and the Risk of Atrial Fibrillation in Athletes: A Literature Review

    by Kamil Marchlik, Julia Tesyna, Melania Czapla, Karolina Kubala, Aleksandra Obszańska, Jakub Tomczyszyn

    Background. Despite the proven positive effects of physical activity on the cardiovascular system, an increasing number of veteran athletes are being diagnosed with atrial fibrillation (AF). Over the past few decades, a growing body of evidence suggests that prolonged endurance training may contribute to the development of AF in certain groups of athletes. The recognition of this link has sparked a debate among researchers regarding the determination of the amount of training at which the risk of AF significantly increases. However, current research findings are inconsistent regarding this relationship; therefore, the relationship between training volume, the type of sport practiced, and the risk of arrhythmia remains not fully understood. Aim. This literature review aims to review the mechanisms involved in the development of atrial fibrillation in athletes and to evaluate the association between exercise volume and the risk of atrial fibrillation. Material and methods. A literature review was conducted using PubMed and Google Scholar. Meta-analyses, systematic reviews, randomized control trials, systematic and literature reviews from past 20 years were analyzed. Results. The strongest available evidence suggests that athletes have approximately 2.5 times the risk of AF compared to the general population. The available data suggest a U-shaped or J-shaped relationship between exercise and the risk of AF. Moderate physical activity still remains cardioprotective. Studies involving the population of female athletes remain limited. Conclusions. The relationship between the risk of AF and physical activity is complex and seems paradoxical. Moderate physical activity has a protective effect, while excessive training increases the risk of AF.

  • Open Access

    The Growing Importance of CA 19-9 in the Diagnosis and Monitoring of Malignant Ovarian Tumors

    by Aleksandra Obszańska, Karolina Kubala, Julia Tesyna, Melania Czapla, Jakub Tomczyszyn, Kamil Marchlik

    Aim: Managing ovarian tumors is a clinical challenge due to vague symptoms, especially in young patients and athletes where saving fertility and avoiding invasive protocols are vital to healthcare quality. This study evaluates the diagnostic and monitoring role of Carbohydrate Antigen 19-9 (CA 19-9) across ovarian tumor histotypes to optimize clinical decisions and patient outcomes. Materials and Methods: A comprehensive review of literature and clinical cohorts evaluating CA 19-9 expression in epithelial ovarian cancers (serous, endometrioid, clear cell, mucinous) and germ cell tumors (mature cystic teratomas) was conducted. Databases were searched for English- and Polish-language studies published up to May 2026. Diagnostic indices, including sensitivity, specificity, and multi-marker panels (CA 19-9 combined with CA 125/HE4), were extracted and synthesized using a narrative approach across core clinical domains. Results: While CA 125 is standard for serous carcinomas, it shows poor sensitivity in clear cell and mucinous histotypes. Conversely, CA 19-9 levels are significantly elevated in mucinous carcinomas (>37 U/mL) and serve as an independent postoperative prognostic marker in clear cell carcinomas when CA 125 is normal. In endometrioid carcinomas, combining CA 19-9 and CA 125 yields a robust specificity of up to 90%. Furthermore, isolated CA 19-9 elevation in mature cystic teratomas strongly correlates with increased tumor size and thinning cyst walls, serving as a vital indicator to estimate acute adnexal torsion risks during physical strain. Conclusions: Integrating CA 19-9 into gynecological panels improves pre-operative differential diagnosis, reduces false-positive rates in active populations, and provides vital risk stratification for ovarian torsion. This multi-marker approach enhances healthcare quality and diagnostic safety in sports medicine and gynecological oncology.

  • Open Access

    THE POTENTIAL ROLE OF L-CARNITINE SUPPLEMENTATION IN MANAGEMENT OF POLYENDOCRINE METABOLIC OVARIAN SYNDROME

    by Melania Czapla, Karolina Kubala, Julia Tesyna, Aleksandra Obszańska, Jakub Tomczyszyn, Kamil Marchlik

    Polyendocrine Metabolic Ovarian Syndrome (PMOS), formerly known as polycystic ovary syndrome, is a common endocrine and metabolic disorder affecting women of reproductive age, characterized by hyperandrogenism, ovulatory dysfunction, and insulin resistance. Despite its high prevalence, its pathophysiology remains incompletely understood, and current therapies are largely symptomatic. Increasing evidence implicates mitochondrial dysfunction, oxidative stress, and chronic low-grade inflammation in disease development. In this context, L-carnitine, a key regulator of mitochondrial fatty acid transport and energy metabolism, has emerged as a potential adjunctive therapeutic agent. This narrative review summarizes current evidence on the role of L-carnitine and its derivatives in PMOS, integrating findings from randomized controlled trials, observational studies, systematic reviews, and preclinical models. Available data suggest that L-carnitine supplementation may improve metabolic parameters, including insulin resistance and lipid profiles, while exerting antioxidant and anti-inflammatory effects in ovarian tissue. However, evidence regarding endocrine and fertility outcomes remains inconsistent. Although preclinical studies strongly support biological plausibility, clinical evidence is limited by heterogeneity in study design, small sample sizes, and reliance on surrogate endpoints. L-carnitine should therefore be considered a promising adjunct rather than a standard treatment for PMOS. Further large-scale randomized controlled trials are required to define optimal dosing, formulation, and patient subgroups most likely to benefit.

  • Open Access

    The future of Escherichia coli vaccines in prevention of recurrent Urinary Tract Disease based on the newest guidelines worldwide.

    by Aleksandra Obszańska, Julia Tesyna, Karolina Kubala, Melania Czapla, Jakub Tomczyszyn, Kamil Marchlik

    Background: Recurrent urinary tract infections (rUTIs), primarily caused by uropathogenic Escherichia coli (UPEC), pose a major global burden. Rising antimicrobial resistance creates an urgent need for non-antibiotic prophylactic strategies, accelerating interest in immunotherapeutics and vaccines. Aim: To evaluate the clinical standing of E. coli immunoprophylaxis in rUTI management under updated 2026 global guidelines, synthesize trial data on historical bacterial extracts, address methodological challenges, and explore emerging target-specific vaccines. Methods: A narrative literature search was conducted using PubMed and Google Scholar for English- and Polish-language studies published up to May 2026, targeting keywords such as "OM-89", "Uro-Vaxom", "E. coli immunotherapy", and "recurrent UTI". Eligible literature included randomized controlled trials, observational studies, systematic reviews, preclinical models, and clinical guidelines. Results: UPEC relies on type 1 fimbrial adhesin (FimH) to adhere to bladder uroepithelium and form intracellular bacterial communities (IBCs). Clinically, the oral extract Uro-Vaxom (OM-89) has historically reduced rUTI frequency and dysuria. However, study heterogeneity and inconsistent outcomes led the European Association of Urology (EAU) to downgrade OM-89's recommendation from strong to weak in 2026. Concurrently, novel subunit vaccines targeting FimH (e.g., adjuvanted FimCH) show promising safety and immunogenicity in early trials, paving the way for Phase 2 evaluation. Conclusions: While OM-89 remains a key non-antibiotic option, updated guidelines highlight the need for standardized, high-quality trials to confirm its efficacy. Next-generation FimH subunit vaccines offer a targeted immunotherapeutic strategy to break the rUTI cycle without driving antimicrobial resistance.

  • Open Access

    ATOGEPANT IN MIGRAINE PREVENTION: A NARRATIVE REVIEW OF PHARMACOLOGY, CLINICAL EFFICACY AND TOLERABILITY

    by Jakub Tomczyszyn, Melania Czapla, Aleksandra Obszańska, Julia Tesyna, Karolina Kubala, Kamil Marchlik

    Migraine is a neurological disorder that involves trigeminal and vascular mechanisms. Pain associated with it is not the only issue. Migraine comes with a significant socioeconomic burden – reduced daily functioning, work productivity and general quality of life. Treatment options for migraine include acute and preventive treatment. Conventional preventive treatments are not always the best option, considering adverse effects, contraindications, quite late benefits and poor long-term adherence. The pathophysiology of migraine led us to the current main therapeutic target – calcitonin gene-related peptide (CGRP). Gepants, including atogepant, are CGRP signaling antagonists. This narrative review analyzes atogepant’s pharmacological profile, currently available evidence about clinical efficacy, tolerability and place of atogepant in migraine management.

  • Open Access

    Effects of creatine on strength, muscle mass, post-exercise recovery and anaerobic capacity in women - literature review

    by Julia Tesyna, Karolina Kubala, Aleksandra Obszańska, Jakub Tomczyszyn, Melania Czapla, Kamil Marchlik

    Introduction: Creatine is one of the most commonly used ergogenic supplements in sport and physical activity. Its primary role is associated with energy metabolism through increasing phosphocreatine stores and supporting rapid ATP resynthesis. Although the effects of creatine supplementation have been extensively studied in men, increasing attention is currently being paid to its influence on women, especially regarding muscle strength, muscle mass, post-exercise recovery, and anaerobic performance. Materials and methods: This study is a narrative literature review based on the analysis of scientific articles concerning creatine supplementation in women. The reviewed studies included physically active women, athletes, and older women participating in resistance or high-intensity exercise programs. Meta-analyses, systematic reviews, randomized control trials, systematic and literature reviews, from past 18 years were analyzed. Aim of the study: The aim of this study was to evaluate the effects of creatine supplementation in women, with particular emphasis on muscle strength, muscle mass, post-exercise recovery, and anaerobic performance. Conclusions: In summary, the available data suggest that creatine supplementation may benefit women in terms of muscle strength and anaerobic performance, particularly when combined with regular training. The effects on muscle mass gain and post-workout recovery remain less conclusive. Despite the growing number of studies, there is still a need for further, well-designed research involving women to more accurately determine the effects of creatine depending on age, physical activity level, and hormonal changes.

  • Open Access

    Overcoming Post-Operative Anabolic Resistance: The Integrated Role of Protein Nutrition and Physical Rehabilitation in Orthopedic Patients

    by Karolina Kubala, Julia Tesyna, Aleksandra Obszańska, Jakub Tomczyszyn, Melania Czapla, Kamil Marchlik

    Introduction: Orthopedic surgery and subsequent disuse trigger a severe systemic stress response. This hostile environment induces anabolic resistance. Consequently, skeletal muscle loses its sensitivity to nutritional inputs and mechanical loading. At the molecular level, the process is driven by a failure of the mTORC1 signaling pathway and accelerated FOXO-mediated proteolysis. Ultimately, these mechanisms cause rapid muscle atrophy, a negative nitrogen balance, and functional decline. Aim: The aim of this narrative review is to examine the molecular and physiological mechanisms of post-operative anabolic resistance and to evaluate how perioperative protein nutrition and mechanical loading combine to restore functional capacity in orthopedic patients. Material and methods: This study was conducted as a narrative review of literature addressing the pathophysiology of post-operative anabolic resistance and integrated recovery strategies in orthopedic patients. A comprehensive literature search was performed using the electronic databases PubMed/MEDLINE, Scopus, Web of Science, the Cochrane Library, and Google Scholar. Results: Post-operative anabolic resistance represents a failure of the mTORC1 signaling path, elevating the leucine threshold needed for net muscle balance. Mechanical loading during rehabilitation acutely enhances muscle sensitivity to amino acids. Consequently, clinical outcomes are optimized when elevated, leucine-rich protein doses (30–40 g/meal, totaling 1.2–2.0 g/kg/day) are evenly distributed. Compared to integrated interventions, standalone nutritional or mechanical protocols exhibit significant variability in their functional endpoints. Conclusions: Post-operative muscle loss is a multi-factorial process requiring a multidisciplinary approach. Overcoming anabolic resistance and accelerating recovery requires fully integrating nutrition into orthopedic rehabilitation, rather than treating it as an isolated intervention.

  • Open Access

    Subcutaneous versus Sublingual Allergen Immunotherapy in Allergic Rhinitis and Asthma: A Comparative Narrative Review

    by Tomasz Pietrucha, Mikołaj Gołdyn, Karolina Kubala, Magdalena Grabińska, Paulina Halik, Justyna Jusiak

    Allergen-specific immunotherapy (AIT) represents the only disease-modifying intervention for IgE-mediated allergic diseases, including allergic rhinitis and allergic asthma. Among the currently available administration routes, subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) are the most extensively studied and clinically implemented. Despite their widespread use, uncertainty persists regarding their relative efficacy, safety, and real-world applicability across different patient populations and allergen types. AIM: The aim of this study was to critically compare the clinical effectiveness, safety profile, and treatment adherence of SCIT and SLIT based on data derived from PubMed-indexed randomized controlled trials, systematic reviews, and meta-analyses. Material and methods: A narrative synthesis of peer-reviewed literature was conducted, focusing on studies directly or indirectly comparing SCIT and SLIT in patients with allergic rhinitis, allergic asthma, or rhinoconjunctivitis. Primary endpoints included symptom score reduction and medication use, while secondary outcomes encompassed adverse events, immunological responses, and adherence rates. Results: Both SCIT and SLIT demonstrated significant clinical efficacy compared with placebo or pharmacotherapy alone. Overall symptom reduction and medication sparing effects were largely comparable between the two modalities. SCIT showed a trend toward slightly greater efficacy in selected allergens, particularly grass pollen, whereas SLIT consistently exhibited a superior safety profile with fewer systemic adverse reactions. Conclusion: SCIT and SLIT are both effective forms of allergen immunotherapy. While SCIT may provide marginal advantages in symptom control in specific clinical contexts, SLIT offers improved safety and convenience. Treatment choice should therefore be individualized, considering patient characteristics, allergen profile, and risk tolerance.


  • Open Access

    Total hip arthroplasty in elderly patients: treatment-specific considerations, risk of complications, and functional outcomes

    by Paulina Halik, Justyna Jusiak, Magdalena Grabińska, Karolina Kubala, Mikołaj Gołdyn, Tomasz Pietrucha, Szymon Stupnicki

    Introduction Total hip arthroplasty (THA) is a widely used and effective procedure for treating advanced hip disorders. With population aging, the number of THA procedures in elderly patients is steadily increasing. Advanced age is associated with comorbidities and reduced physiological reserve, which may influence perioperative risk and postoperative outcomes. Aim This review aimed to summarize current evidence on total hip arthroplasty in elderly patients, focusing on surgical management, perioperative care, rehabilitation, and clinical outcomes. Materials and methods A narrative review of the literature was conducted using PubMed, Scopus, and Web of Science databases. Publications between 2001 and 2025 were included. The review focused on adults aged ≥65 years and synthesized findings narratively across surgical indications and management, perioperative care, risk of complications, rehabilitation, and functional outcomes following total hip arthroplasty. Results Available evidence indicates that THA provides significant pain relief and functional improvement in elderly patients, including those aged 80 years and older. Cemented implants are associated with lower early revision rates and better implant survival in patients with poor bone quality, while uncemented and hybrid prostheses may be appropriate in selected cases. Elderly patients have a higher risk of perioperative complications, such as cardiopulmonary events, delirium, and periprosthetic fractures. Early mobilization and structured rehabilitation significantly improve functional recovery and reduce complication rates. Conclusion Total hip arthroplasty is a safe and effective treatment option for elderly patients when individualized surgical planning, comprehensive perioperative management, and multidisciplinary rehabilitation are applied. Advanced age alone should not be considered a contraindication to surgery.

  • Open Access

    Breast Cancer Risk in Users of Hormonal Contraception

    by Magdalena Grabińska, Aleksandra Buda, Paulina Halik, Justyna Jusiak, Tomasz Pietrucha, Mikołaj Gołdyn, Karolina Kubala, Adam Dudek, Daniel Zieliński, Małgorzata Sędek

    Combined oral contraceptives (COCs) are a widely used method of birth control among women. They have a low Pearl Index, confirming high efficacy. Their mechanism of action relies on suppression of ovulation. This is achieved through the influence of estrogenic and progestogenic components on the release of follicle-stimulating hormone and luteinizing hormone from the pituitary gland. COCs also inhibit fertilization by altering cervical mucus composition and prevent blastocyst implantation. The mechanism of action of COCs allows their use for non-contraceptive purposes. For example, they reduce the risk of ovarian and endometrial cancer. They also limit menstrual bleeding and alleviate acne, migraine headaches, and dysphoric symptoms. Conversely, adverse effects of COCs include an increased risk of cervical cancer. Their impact on breast cancer remains inconclusive. Clinical studies have demonstrated that the overall incidence of breast cancer among women using COCs is comparable to that among women who have never used them. However, during COC use and shortly after discontinuation, the risk of developing breast cancer is elevated, whereas it decreases five years after cessation. Among women with BRCA1 or BRCA2 mutations, the impact of COCs remains uncertain, with some studies reporting increased risk and others suggesting a reduction. Breast cancer is the most frequently diagnosed malignancy among women and the second leading cause of cancer-related death. Prognosis is often dependent on the stage at diagnosis. Mortality risk due to breast cancer is higher among women using COCs, whereas it does not significantly change with the use of progestin-only oral contraceptives. Some patients discontinue oral contraception due to concerns about adverse effects and a potential increase in breast cancer risk. The aim of this study was to present the mechanisms of COC action within breast tissue and their influence on the risk of breast cancer.